Global Active Humidifier Devices Market is estimated to reach USD 1,206.9 Million by 2033 Faces Modest Decline, Yet Innovation and Safety Drive Future Prospects | Future Market Insights, Inc.

The United States is projected to remain a key market for active humidifier devices, driven by increasing demand in healthcare, residential, and industrial applications, focusing on improved air quality and health benefits.

/EIN News/ -- NEWARK, Del, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The global active humidifier devices market, a key player in respiratory care, is poised to experience a modest decline over the next decade. Valued at USD 1,264.4 million in 2023, the market is projected to decrease slightly to USD 1,206.9 million by 2033, reflecting a compound annual growth rate (CAGR) of -0.5%.

The market witnessed extraordinary growth during the COVID-19 pandemic, driven by an impressive CAGR of 28.7%. Active humidifiers became indispensable in respiratory support, especially for patients on mechanical ventilation, where humidified air contributed significantly to improved respiratory outcomes. The surge in demand prompted manufacturers to introduce a wide range of innovative devices, which proved lifesaving for countless patients during the crisis.

However, as the global healthcare landscape stabilizes post-pandemic, the need for active humidifier devices has diminished, leading to a gradual decline in market growth. Additionally, the industry faces challenges related to device safety, particularly concerning water buildup in tubing circuits and infection risks. These concerns have prompted a wave of innovation in the sector, with manufacturers focusing on developing safer, more efficient alternatives to address these critical issues.

Despite the current contraction in market growth, experts remain cautiously optimistic about the future of the active humidifier devices market. The ongoing advancements in respiratory care technology suggest a potential recovery, driven by next-generation solutions aimed at enhancing patient safety and improving overall care. As the industry evolves, manufacturers are poised to create more effective, reliable devices that could fuel the market's resurgence in the years to come.

In conclusion, while the active humidifier devices market may be experiencing a temporary decline, its long-term outlook remains positive, thanks to continued innovation and the growing demand for safer and more advanced respiratory care solutions.

Regional Insights

• North America is set to maintain a leading position, with an estimated market share of over 29.4% in 2023. The United States alone is projected to capture a significant share of above 27.8%.
• Europe follows, with an anticipated value share of over 12.2% in 2023. Germany, in particular, holds a notable 4% share of the global market.
• Japan is expected to contribute a value share exceeding 9.7%.
• Conversely, Australia and India are projected to experience negative growth rates of -1.3% and -2.8%, respectively.
• China is expected to exhibit a modest CAGR of 1.5% from 2023 to 2033.
• The United Kingdom is anticipated to see a minimal growth rate of 0.1% CAGR.

Product and Application Insights

• Electronic humidifiers are expected to dominate, holding a projected value share of 55.79%.
• Adults are the primary users, accounting for 87.99% of the market.
• The invasive ventilation segment is a major contributor, representing 47% of market growth.
• Hospitals are the largest end-users, forming 64.5% of the market share.

Access the Full Report for In-Depth Insights Now! https://www.futuremarketinsights.com/reports/active-humidifier-devices-market

Historical Developments and Long-term Strategies:

Active humidifier device manufacturers have faced a decline from the historical high growth driven by COVID-19. For instance, Hamilton Medical's introduction of the H900 active humidifier in 2016 marked a significant advancement in the industry.

To navigate current challenges, key players are focusing on strategic collaborations, partnerships, and acquisitions. Recent notable developments include:

• Vadi Medical Technology’s expansion of its product line with the VH3000-220 Humidifier in January 2021.
• Intersurgical Ltd.’s establishment of a new office in Canada to enhance product availability.
• WILAmed GmbH’s launch of the AIRcon Gen2 Respiratory Humidifier in 2019.
  
  

Market Dominance by Key Players in the Market:

• Fisher & Paykel Healthcare Limited
• Koninklijke Philips N.V.(Philips Respironics)
• Vapotherm
• Teleflex Corporation
• ResMed Corporation
• VINCENT MEDICAL HOLDINGS LIMITED
• Armstrong Medical (an Eakin Company)
• Breas Medical AB (Subsidiary of Fosun Pharma)
• BMC Medical Co., Ltd
• Hamilton Medical AG
• SunMed
• WILAmed GmbH
• Flexicare (Group) Limited
• Penlon Limited
• DEAS S.R.L.
• Intersurgical Ltd
• Beijing Aeonmed Co., Ltd.
• Shenyang RMS MEDICAL TECH CO., LTD
• GaleMed Corporation
• Vadi Medical Technology Co, Ltd.

Active Humidifier Devices by Category:

Product Type:

• Heated/electronic Humidifiers
• Bubble Humidifiers
• Accessories
  

Age Group:

• Adult
• Pediatric
• Neonates
  

Application:

• Invasive Ventilation
• Non-invasive Ventilation
  • nCPAP (Nasal Continuous Positive Airway Pressure)
  • Bubble CPAP (Bubble Continuous Positive Airway Pressure)
• High Flow Oxygen Therapy
  

End User:

• Hospitals
  • Less than 100 Beds
  • 100-300 Beds
  • 300-500 Beds
  • 500 Beds and More
• Ambulatory Surgical Centers
• Sleep Centers
  

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)
  
  

Old Source: https://www.pharmiweb.com/press-release/2023-06-29/abated-coronavirus-cases-a-threat-to-active-humidifier-devices-market-industry-to-observe-05-cag

French Translation:
Le marché mondial des humidificateurs actifs, un acteur clé des soins respiratoires, est sur le point de connaître un léger déclin au cours de la prochaine décennie. Évalué à 1 264,4 millions USD en 2023, le marché devrait légèrement diminuer à 1 206,9 millions USD d’ici 2033, reflétant un taux de croissance annuel composé (TCAC) de -0,5 %.

Le marché a connu une croissance extraordinaire pendant la pandémie de COVID-19, stimulée par un TCAC impressionnant de 28,7 %. Les humidificateurs actifs sont devenus indispensables dans l’assistance respiratoire, en particulier pour les patients sous ventilation mécanique, où l’air humidifié a contribué de manière significative à l’amélioration des résultats respiratoires. L’augmentation de la demande a incité les fabricants à introduire une large gamme d’appareils innovants, qui ont sauvé la vie d’innombrables patients pendant la crise.

Cependant, à mesure que le paysage mondial des soins de santé se stabilise après la pandémie, le besoin d’humidificateurs actifs a diminué, ce qui a entraîné un déclin progressif de la croissance du marché. De plus, l’industrie est confrontée à des défis liés à la sécurité des appareils, notamment en ce qui concerne l’accumulation d’eau dans les circuits de tubes et les risques d’infection. Ces préoccupations ont déclenché une vague d’innovation dans le secteur, les fabricants se concentrant sur le développement d’alternatives plus sûres et plus efficaces pour résoudre ces problèmes critiques.

Malgré la contraction actuelle de la croissance du marché, les experts restent prudemment optimistes quant à l’avenir du marché des humidificateurs actifs. Les progrès continus dans la technologie des soins respiratoires suggèrent une reprise potentielle, stimulée par des solutions de nouvelle génération visant à améliorer la sécurité des patients et les soins globaux. À mesure que l’industrie évolue, les fabricants sont prêts à créer des appareils plus efficaces et plus fiables qui pourraient alimenter la résurgence du marché dans les années à venir.

En conclusion, alors que le marché des humidificateurs actifs connaît peut-être un déclin temporaire, ses perspectives à long terme restent positives, grâce à l’innovation continue et à la demande croissante de solutions de soins respiratoires plus sûres et plus avancées.

Aperçus régionaux

• L’Amérique du Nord devrait conserver une position de leader, avec une part de marché estimée à plus de 29,4 % en 2023. Les États-Unis à eux seuls devraient capter une part importante de plus de 27,8 %.
• L’Europe suit, avec une part de valeur prévue de plus de 12,2 % en 2023. L’Allemagne, en particulier, détient une part notable de 4 % du marché mondial.
• Le Japon devrait représenter une part de valeur supérieure à 9,7 %.
• À l’inverse, l’Australie et l’Inde devraient connaître des taux de croissance négatifs de -1,3 % et -2,8 %, respectivement.
• La Chine devrait afficher un TCAC modeste de 1,5 % de 2023 à 2033.
• Le Royaume-Uni devrait connaître un taux de croissance minimal de 0,1 % TCAC.

Informations sur les produits et les applications

• Les humidificateurs électroniques devraient dominer, avec une part de valeur projetée de 55,79 %.
• Les adultes sont les principaux utilisateurs, représentant 87,99 % du marché.
• Le segment de la ventilation invasive est un contributeur majeur, représentant 47 % de la croissance du marché.
• Les hôpitaux sont les plus grands utilisateurs finaux, représentant 64,5 % des parts de marché.

Développements historiques et stratégies à long terme :

Les fabricants d’humidificateurs actifs ont été confrontés à un déclin par rapport à la forte croissance historique entraînée par COVID-19. Par exemple, l’introduction de l’humidificateur actif H900 par Hamilton Medical en 2016 a marqué une avancée significative dans l’industrie.

Pour relever les défis actuels, les principaux acteurs se concentrent sur les collaborations stratégiques, les partenariats et les acquisitions. Parmi les développements notables récents, citons :

• L’expansion de la gamme de produits de Vadi Medical Technology avec l’humidificateur VH3000-220 en janvier 2021.
• l’établissement d’un nouveau bureau au Canada par Intersurgical Ltd. afin d’améliorer la disponibilité des produits.
• Lancement par WILAmed GmbH de l’humidificateur respiratoire AIRcon Gen2 en 2019.
  
  

Position dominante du marché par les principaux acteurs du marché :

• Fisher & Paykel Healthcare Limited
• Koninklijke Philips N.V.(Philips Respironics)
• Vapotherm
• Société Teleflex
• Société ResMed
• VINCENT MEDICAL HOLDINGS LIMITED
• Armstrong Medical (une société Eakin)
• Breas Medical AB (filiale de Fosun Pharma)
• BMC Medical Co., Ltd
• Hamilton Medical AG
• SunMed
• WILAmed GmbH
• Flexicare (Groupe) Limitée
• Penlon Limited
• DEAS S.R.L.
• Intersurgical Ltd
• Beijing Aeonmed Co., Ltd.
• Shenyang RMS MEDICAL TECH CO., LTD
• Société GaleMed
• Vadi Medical Technology Co, Ltd.

Humidificateurs actifs par catégorie :

Type de produit :

• Humidificateurs chauffants/électroniques
• Humidificateurs à bulles
• Accessoires
  
  

Groupe:

• Adulte
• Pédiatrique
• Nouveau-nés
  
  

Application:

• Invasive Ventilation
• Ventilation non invasive
  • nCPAP (pression positive continue nasale)
  • CPAP à bulles (Bubble Continuous Positive Way Pressure)
• Oxygénothérapie à haut débit
  
  

Utilisateur final:

• Hôpitaux
  • Moins de 100 lits
  • 100-300 lits
  • 300-500 lits
  • 500 lits et plus
• Centres de chirurgie ambulatoire
• Centres du sommeil
  
  

Région:

• Amérique du Nord
• Amérique Latine
• Europe
• Asie de l’Est
• Asie du Sud
• Océanie
• Moyen-Orient et Afrique (MEA)
  
  

Authored By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

The global portable medical devices market size is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of USD 163.84 billion by 2033, increasing from USD 59.28 billion in 2023.

The global medical ventilators market share is expected to hold a market value of USD 1.7 billion in 2023. The market is expected to advance at 9.1% between 2023 and 2033. By 2033, the market is projected to cross USD 4 billion.

The global antioxidants reagents market demand are estimated to be worth USD 2,615.8 million in 2024 and anticipated to reach a value of USD 5,543.5 million by 2034. Sales are projected to rise at a CAGR of 7.8% over the forecast period between 2024 and 2034.

The global reagent filling systems market trends are estimated to be worth USD 10,253.6 million in 2024 and anticipated to reach a value of USD 18,190.1 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.

The medical telepresence robots market outlook is estimated to reach USD 70.5 million in 2024. It is estimated that revenue will increase at a CAGR of 4.4% between 2024 and 2034. The market is anticipated to reach USD 110.5 million by 2034.

The global sales of lung cancer therapeutics are estimated to be worth USD 33,828.7 million in 2024 and anticipated to reach a value of USD 65,926.9 million by 2034. Sales are projected to rise at a CAGR of 6.9% over the forecast period between 2024 and 2034.

Computer Vision in Healthcare Market Growth is expected to expand from USD 2.5 billion in 2024 to USD 56.1 billion by 2034. By 2034, the market is projected to surge at 36.7% CAGR.

Ophthalmic Surgical Market Development is expected to grow at a CAGR of 5.7% from 2024 to 2034. The market value is projected to increase from USD 13,937.8 million in 2024 to USD 24,194.2 million by 2034.

Ultrasound Market Opportunity is set to be valued at USD 11.70 billion in 2024 and is projected to reach USD 20.40 billion by 2034, exhibiting a modest CAGR of 5.80% over the forecast period.

Synthetic Biology Market Forecast is expected to rise from USD 3.75 billion in 2024 to USD 31.73 billion by 2034, growing at a lucrative 23.8% CAGR over the forecast period.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube